- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Morepen Laboratories Limited has announced a board meeting to discuss the financial results for the quarter and half-year ended 30th September 2024. The consolidated total income from operations for this period was ₹43,772.61 crore, with a net profit after tax of ₹3,484.86 crore. This indicates a strong performance compared to previous quarters.
The results reflect solid operational efficiency, suggesting potential growth opportunities. Investors may view these results positively, considering the consistent revenue and profit uptick, which could enhance shareholder value moving forward.